HHS authorizes $81M in Zika vax funding after Congressional gridlock

An article by FiercePharma
August 17, 2016

While U.S. lawmakers are out on summer vacation, the urgency to develop an effective Zika vaccine remains. And so HHS Secretary Sylvia Burwell has signed off on an $81 million fund allocation for federal agencies to continue research, though officials are stressing the amount is far shy of what is really needed.

In a letter to U.S. House of Representatives minority leader Nancy Pelosi, Burwell said $34 million would go to the NIH while BARDA would get $47 million “in order to ensure that neither is forced to delay their Zika vaccine work as the fiscal year closes.”

The NIAID, which has entered the clinic with a DNA-based Zika vaccine candidate, will use its money to prepare for a move into Phase II. At a press briefing, director Anthony Fauci said that Phase I is expected to wrap up at the end of this year, but that the NIAID needs nearly $200 million more for its work, according to Reuters. Burwell said NIH has three more candidates under development, but no resources to support them.

BARDA’s tranche will allow the agency to enter into contracts with private partners, but that agency will need another $342 million next year, Burwell said.


Read more here